Answers are grounded in this paper and cite their sources.
Cross-sectional study evaluates aspirin eligibility for cardiovascular disease, suggesting new guidelines for primary prevention.
This cross-sectional study examines eligibility for aspirin for the primary prevention of cardiovascular disease based on the pooled cohort equations and the Predicting Risk of Cardiovascular Disease EVENTs equations.
No takes yet. Share an insight, caveat, or question.
Sayed et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: